Temtumの‌価格TEM

The latest portfolio activity of the Cathie Wood-led investment firm Ark Invest has revealed a major investment in Circle shares. Following the debut of CRCL , the long-awaited initial public offering of stablecoin issuer Circle on the New York Stock Exchange, Wood’s Ark Invest poured an estimated $373 million into the stock, acquiring a total of 4.5 million shares. The purchases were spread across three of Ark’s actively managed ETFs: 1) ARK Innovation ETF (ARKK), 2) ARK Next Generation Internet ETF (ARKW), and 3) ARK Fintech Innovation ETF (ARKF), allocating 3,025,089 CRCL, 927,318 CRCL, and 524,153 CRCL, respectively. Here's every move Cathie Wood and Ark Invest made in the Stock Market today 6/5 pic.twitter.com/6SKx1cPCfP Circle’s stock opened for trading on the NYSE on June 5. The stablecoin issuer priced its IPO at $31 per share but opened for trading at $69. Shares hit an intra day high of $103.75 before giving back some gains and closing the day at $83.23. The new purchase followed some selling activity. Ark Invest trimmed positions in Coinbase’s COIN, Robinhood’s HOOD, and its own Bitcoin ETF, ARKB. Cathie Wood is renowned for her vocal advocacy for Bitcoin and the crypto industry, and the latest purchase highlights her reputation of strategic portfolio diversification. The latest CRCL acquisition is not ARK’s only large-scale investment. Just days earlier, the firm increased its stake in TEM, the native stock of the health-tech company using artificial intelligence to enhance clinical diagnostics Tempus AI, to a total of $284.8 million. Ark Invest also holds significant positions across several other major players such as Tesla (TSLA), Nvidia (NVDA), Advanced Micro Devices (AMD), and Intellia Therapeutics (NTLA).

Cathie Wood’s Ark Invest bets big on emerging health-tech leader, Tempus AI, with latest multi-million dollar investment. Cathie Wood , the CEO and co-founder of investment firm Ark Invest renowned for her proactive approach to asset maneuvers, is currently diversifying her portfolio with fresh acquisitions. This time, Wood’s focus is turned to the native stock of the health artificial intelligence firm Tempus AI, TEM. On May 28, 2025, Wood’s Ark funds acquired 251,080 TEM, valued at approximately $13.9 million based on the stock’s closing price as of May 30. The purchase followed a short-term dip in Tempus AI’s share price, echoing Ark’s strategy of buying during market pullbacks. Tempus AI, which recently went public leverages artificial intelligence to personalize cancer care and other complex medical treatments. The investment aligns with Wood’s belief in AI as a transformative force across sectors such as healthcare. Wood’s Ark’s latest move is not isolated, but part of a broader buying trend that began in June 2024. With its latest purchase, Ark Invest’s total holdings in Tempus AI have surged to $284.8 million, making it the sixth-largest position across its actively managed ETFs and accounting for roughly 5% of its total portfolio. Here are the current largest holdings in Cathie Wood and Ark Invest's Genomic Revolution ETF $ARKG 🥇 Tempus AI $TEM 🥈 Crispr $CRSP 🥉 Twist $TWST pic.twitter.com/qtOy6DpPfX The latest acquisition follows a series of similar purchases of in major players like Nvidia (NVDA), Advanced Micro Devices (AMD), and Intellia Therapeutics (NTLA), among others. Meanwhile, Ark Invest has also been trimming positions in other major holdings. Recent sell-offs include Tesla (TSLA), Roblox (RBLX), and CoreWeave (CRWV). Cathie Wood’s Ark Invest is also known for holding positions in major crypto shares like COIN, as well as its own Bitcoin ETF , ARKB.

RT @TheOG_General: Brasil, escuta! Quer entrar na comunidade $DOG mas não tem grana pra comprar? Sem stress — essa revolução meme é pra TOD…

RT @Brainiac_OG: Toda vez que você ver alguém falando de $DOG, saiba: é real 🔥 Não tem time por trás, nem grana rolando por DM. Ninguém é p…

Trench Bot referral sy$tem 🪖🤖💸👇